RNA Vacciné - Search News

FDA won't consider a new mRNA vaccine for flu

FDA won’t consider a new mRNA vaccine for flu despite the technology’s life-saving promise

The U.S. Food and Drug Administration is refusing to consider a new mRNA flu vaccine made by Moderna, the company revealed in a statement on Tuesday.

Dealbreaker on MSN · 1d

Moderna says FDA refusal to review mRNA flu vaccine contradicts federal rules, prior guidance

· 3d

F.D.A. Refuses to Review Moderna Flu Vaccine

· 1d

FDA defends its decision to refuse review of Moderna's flu vaccine

Shares of Moderna (MRNA.O) slumped nearly 9% in premarket trading on Wednesday after the U.S. Food and Drug Administration declined to review the company's application for approval of its experimental...

· 12h

Moderna beats quarterly revenue estimates on resilient sales of COVID shot

· 1d

FDA refuses Moderna's application for new mRNA flu vaccine

14d

Moderna Vs. Novavax: 2 Pandemic Vaccine Pioneers - Which Offers Better Value Today?

Moderna, Inc. vs. Novavax, Inc.: cost cuts, vaccine pipeline catalysts, and valuations. Click for this comparison of NVAX and MRNA and see which is better for you.

Healio

More data show mRNA COVID-19 vaccination during pregnancy is safe

The messenger RNA COVID-19 vaccine is not tied to neurodevelopmental disorders in youth whose mothers who were vaccinated immediately before or during pregnancy, data show.The study, presented at The Pregnancy Meeting and “conducted through a rigorous scientific process in an NIH clinical trials network,